A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC
- Status
- WITHDRAWN
- Phase
- PHASE2
CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Chemoimmunotherapy for High-Risk Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Xeloxiri Regimen for Patients With Refractory Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status
- Status
- COMPLETED
- Phase
- PHASE2
Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas
- Status
- COMPLETED
- Phase
- PHASE2
Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJA
- Status
- UNKNOWN
- Phase
- PHASE2
Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC
- Status
- UNKNOWN
- Phase
- PHASE3
Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2